Fig. 5From: Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa studyKaplan-Meier plots of overall survival. Kaplan-Meier survival estimates are presented for (a) All patients (n = 44): median OS was 29.3 months 95 % CI: [21.2; n.a]. (b) Patients with metastatic disease (n = 36): median OS was 31.4 months 95 % CI: [21.2; n.a.]Back to article page